PRESS RELEASE published on 09/17/2025 at 22:15, 2 months 17 days ago NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-P NanoBiotix annonce de nouveaux résultats de phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1 NANOBIOTIX Phase 1 Inhibiteurs De Points De Contrôle JNJ-1900 Mélanome Cutané
BRIEF published on 09/12/2025 at 19:05, 2 months 22 days ago Nanobiotix annonce les droits de vote et le détail du capital social Euronext Actions Nasdaq Droit De Vote NANOBIOTIX
BRIEF published on 09/12/2025 at 19:05, 2 months 22 days ago Nanobiotix Announces Voting Rights and Share Capital Details Voting Rights Shares Euronext Nasdaq NANOBIOTIX
PRESS RELEASE published on 09/12/2025 at 19:00, 2 months 22 days ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL Communiqué de presse sur le nombre total de droits de vote et d'actions de Nanobiotix. Informations financières clés et activités de l'entreprise Droits De Vote Capital Social Biotechnologie Actions NANOBIOTIX
PRESS RELEASE published on 09/12/2025 at 19:00, 2 months 22 days ago Voting Rights and Shares Capital of the Company Nanobiotix releases voting rights and shares capital details. The company is listed on Euronext Paris and Nasdaq, pioneering biotechnology for treatment advancements Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 09/02/2025 at 22:20, 3 months 2 days ago Nanobiotix à la conférence H.C. Wainwright Global Investment Biotechnologie Investisseurs Conference NANOBIOTIX Thérapeutiques
BRIEF published on 09/02/2025 at 22:20, 3 months 2 days ago Nanobiotix at the HC Wainwright Global Investment Conference Investors Biotechnology Conference Therapeutics NANOBIOTIX
PRESS RELEASE published on 09/02/2025 at 22:15, 3 months 2 days ago Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment Nanobiotix participe à la conférence investisseurs annuelle H.C. Wainwright Global Investment pour présenter ses avancées en biotechnologie pour le traitement du cancer et d'autres maladies Biotechnologie Conférence Investisseurs Cancer NANOBIOTIX Maladies
PRESS RELEASE published on 09/02/2025 at 22:15, 3 months 2 days ago Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Nanobiotix to participate in H.C. Wainwright 27th Annual Global Investment Conference with a fireside chat featuring company management. Nanoparticle-based treatments for cancer and major diseases Fireside Chat NANOBIOTIX H.C. Wainwright Conference Late-stage Biotechnology Nanoparticle-based Treatments
BRIEF published on 08/27/2025 at 08:05, 3 months 9 days ago Nanobiotix annonce une mise à jour des droits de vote et du capital social Euronext Paris Capital Social Biotechnologie Droit De Vote NANOBIOTIX
Published on 12/05/2025 at 16:00, 58 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 13 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 13 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 1 hour 23 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 16:25, 33 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 48 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 58 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 58 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 58 minutes ago Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 15:10, 1 hour 47 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 47 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 59 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 8 hours 13 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 8 hours 13 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry